Ted Gooley
Associate Professor
Biostatistics
Fred Hutchinson Cancer Rearch Center
United States of America
Biography
Ted Gooley received a Bachelor’s degree in Mathematics from Washington State University in Pullman (Go Cougs!). He obtained his PhD from the Program in Applied Mathematics at the University of Arizona in Tucson. After a one-year post-doctoral position at the University of Rochester (New York), he joined the Clinical Research Division at Fred Hutch and has been here since 1992, where he has been involved in numerous studies (both clinical trials and observational studies) in the area of hematopoietic cell transplant. Outside the workplace, Ted enjoys time with his wife and their daughter. He also has a passion for sports and is known to be willing to discuss such matters with anyone who is interested, particularly when it comes to March Madness.
Research Interest
Clinical trials and methods of data analysis in stem cell transplantation.
Publications
-
Petersdorf EW, Gooley TA, Malkki M, Bacigalupo AP, Cesbron A, Du Toit E, Ehninger G, Egeland T, Fischer GF, Gervais T et al.. 2014. HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.. Blood. 124(26):3996-4003
-
Green DJ, Orgun NN, Jones JC, Hylarides MD, Pagel JM, Hamlin DK, Wilbur DS, Lin Y, Fisher DR, Kenoyer AL et al.. 2014. A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies.. Cancer research. 74(4):1179-89
-
El-Gazzar A, Cai X, Reeves RS, Dai Z, Caballero-Benitez A, McDonald DL, Vazquez J, Gooley TA, Sale GE, Spies T et al.. 2014. Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells.. Oncogene. 33(41):4932-40
-
Cassaday RD, Stevenson PA, Gooley TA, Chauncey TR, Pagel JM, Rajendran J, Till BG, Philip M, Orozco JJ, Bensinger WI et al.. 2015. High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.. British journal of haematology. 171(5):788-97
-
Festuccia M, Deeg HJ, Gooley TA, Baker K, Wood BL, Fang M, Sandmaier BM, Scott BL. 2016. Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(7):1227-33.
